Valuation Vertex Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX 03:20:39 2026-09-17 pm EDT			5-day change	1st Jan Change
512.56 ^USD	-0.14%		-0.27%	+13.19%

Sep. 14	Vertex Pharmaceuticals Incorporated Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 07:00 AM
Sep. 10	Vertex Pharmaceuticals Incorporated Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference, Sep-10-2026 02:10 PM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	130,091	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	13.1%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	125,814	122,551	121,595
Change	-	31.13%	47.8%	4.23%	11.09%	16.05%	-2.59%	-0.78%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	52.8x	27.8x	23.5x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	8.33x	6.61x	5.36x
PEG	-	0.5x	3.51x	2x	-0x	-1.4x	0.3x	1.3x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	9.82x	8.96x	7.93x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	9.5x	8.44x	7.41x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	32.6x	19.7x	17.7x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	26.1x	20.4x	17.6x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	69.8x	26.3x	24x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	1.43%	3.81%	4.16%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	9.729	18.45	21.85
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,248	14,526	16,400
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	3,864	6,205	6,860
EBIT ¹	4,344	4,793	4,375	695.6	5,263	4,813	6,000	6,928
Net income ¹	2,342	3,322	3,620	-535.6	3,953	2,535	4,831	5,688
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-4,277	-7,540	-8,497
Reference price ²	219.60	288.78	406.89	402.70	453.36	513.26	513.26	513.26
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,461	-	-
Announcement Date	1/26/22	2/7/23	2/5/24	2/10/25	2/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	52.76x	9.5x	32.56x	-.--%	130B
ELI LILLY AND COMPANY	32.35x	11.76x	23.85x	0.61%	1,014B
JOHNSON & JOHNSON	29.73x	6.61x	18.52x	2.01%	644B
ABBVIE INC.	33.2x	7.77x	16.07x	2.61%	464B
ROCHE HOLDING AG	19.64x	4.8x	11.88x	2.76%	354B
NOVARTIS AG	19.71x	5.15x	12.77x	3.12%	265B
ASTRAZENECA PLC	20.89x	4.31x	12.32x	2.04%	253B
AMGEN INC.	23.89x	6.29x	11.2x	2.68%	203B
NOVO NORDISK A/S	12.12x	4.42x	9.24x	4.14%	186B
GILEAD SCIENCES, INC.	-44.67x	6.51x	25.43x	2.23%	183B
Average	19.96x	6.71x	17.38x	2.22%	369.69B
Weighted average by Cap.	24.51x	7.70x	18.17x	1.94%